Yong L. Hu

Author Correction: DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury.

Journal: Cellular & molecular immunology

Published: July 16, 2026

Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation OncologyBiologyPhysics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].

Journal: International journal of radiation oncology, biology, physics

Published: July 06, 2026

Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure.

Journal: Bioorganic chemistry

Published: March 17, 2026

Stereotactic Body Radiation Therapy With Continued First-Line PD-1 Inhibitor-based Therapy as a Resistance-Overcoming Strategy in Oligoprogressive Hepatocellular Carcinoma: A Prospective Phase 2 Clinical Study.

Journal: International journal of radiation oncology, biology, physics

Published: April 03, 2025

SNX25-mediated regulation of NGF by Periploca sepium periplosides from Xiangjiapi in macrophage-dependent anti-nociception.

Journal: Science China. Life sciences

Published: January 18, 2025

Enhancing Chemotherapy Efficacy via an Autologous Erythrocyte-Anchoring Strategy with a Closed-System Drug-Transfer Device.

Journal: ACS biomaterials science & engineering

Published: December 19, 2024

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers.

Journal: BMC cancer

Published: October 15, 2024

Impact of ground-glass component on prognosis in early-stage lung cancer treated with stereotactic body radiotherapy via Helical Tomotherapy.

Journal: Radiation oncology (London, England)

Published: August 27, 2024

External Beam Radiation therapy After Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for Treatment of Inoperable Hepatocellular Carcinoma: A Randomized Phase 3 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: April 30, 2024

Radiotherapy enhances efficacy of PD-1 inhibitors in advanced hepatocellular carcinoma: A propensity-matched real-world study.

Journal: Chinese medical journal

Published: December 26, 2023

Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma.

Journal: Canadian journal of gastroenterology & hepatology

Published: October 25, 2023

Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy.

Journal: Clinical and experimental immunology

Published: October 22, 2023

Author Correction: DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury.

Author Correction: DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury.

Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation Oncology*Biology*Physics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].

Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation Oncology*Biology*Physics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].

Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure.

Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure.

Stereotactic Body Radiation Therapy With Continued First-Line PD-1 Inhibitor-based Therapy as a Resistance-Overcoming Strategy in Oligoprogressive Hepatocellular Carcinoma: A Prospective Phase 2 Clinical Study.

Stereotactic Body Radiation Therapy With Continued First-Line PD-1 Inhibitor-based Therapy as a Resistance-Overcoming Strategy in Oligoprogressive Hepatocellular Carcinoma: A Prospective Phase 2 Clinical Study.

SNX25-mediated regulation of NGF by Periploca sepium periplosides from Xiangjiapi in macrophage-dependent anti-nociception.

SNX25-mediated regulation of NGF by Periploca sepium periplosides from Xiangjiapi in macrophage-dependent anti-nociception.

Enhancing Chemotherapy Efficacy via an Autologous Erythrocyte-Anchoring Strategy with a Closed-System Drug-Transfer Device.

Enhancing Chemotherapy Efficacy via an Autologous Erythrocyte-Anchoring Strategy with a Closed-System Drug-Transfer Device.

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers.

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers.

Impact of ground-glass component on prognosis in early-stage lung cancer treated with stereotactic body radiotherapy via Helical Tomotherapy.

Impact of ground-glass component on prognosis in early-stage lung cancer treated with stereotactic body radiotherapy via Helical Tomotherapy.

External Beam Radiation therapy After Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for Treatment of Inoperable Hepatocellular Carcinoma: A Randomized Phase 3 Trial.

External Beam Radiation therapy After Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for Treatment of Inoperable Hepatocellular Carcinoma: A Randomized Phase 3 Trial.

Radiotherapy enhances efficacy of PD-1 inhibitors in advanced hepatocellular carcinoma: A propensity-matched real-world study.

Radiotherapy enhances efficacy of PD-1 inhibitors in advanced hepatocellular carcinoma: A propensity-matched real-world study.

Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma.

Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma.

Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy.

Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy.

Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation OncologyBiologyPhysics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].

Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation OncologyBiologyPhysics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].